Novartis in Society Integrated Report 2023
This report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.
Annual Report 2023 and US Securities & Exchange Commission Form 20-F 2023
These reports provide a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices. They are filed with the SIX Swiss Exchange in Switzerland and the Securities and Exchange Commission in the US.
Other reporting documents
Additional documents, including downloadable data from the Novartis in Society Integrated Report, our latest TCFD disclosure and additional regulatory disclosures.
- Novartis Report on Child Labor Due Diligence in our Supply Chain 2023 (PDF 0.6 MB)
Novartis complies with the due diligence obligations regarding child labor required by the Swiss Code of Obligations.
- Reporting Criteria for Novartis in Society Integrated Report (NiS) 2023 (PDF 0.7 MB)
Definitions, methodologies and assumptions for nonfinancial indicators in the report that are assured by our external auditor.
- Novartis ESG Data Summary 2023 (ZIP 0.1 MB)
Download nonfinancial performance indicators published in the Novartis in Society Integrated Report 2023.
- Task Force on Climate-related Financial Disclosures (TCFD) report 2023 (PDF 0.4 MB)
Download our latest disclosure in alignment with the recommendations of the Task Force on Climate-related Financial Disclosures.
- US SEC Form SD 2022 - Conflict Minerals Report (PDF 0.2 MB)
We disclose annually to the US Securities and Exchange Commission our use of certain minerals and their origins.
- Global Materiality Assessment 2021 Results Report (PDF 1.7 MB)
Our most recent assessment of the issues that present the most significant risks and opportunities for our business and where we have the most impact.
- UK and Australia Joint Modern Slavery Statement 2022 (PDF 0.3 MB)
Our statement under UK and Australian legislation on our efforts to address modern slavery.
We aim for sustainable performance over time to benefit patients, employees, shareholders and society.
As part of our ongoing commitment to transparency, we publish our positions on various issues affecting our business. We are also transparent about our values and behaviors, our approach to managing ethical decisions, and the standards we expect of our suppliers. This section includes many of the policies, codes, guidelines and commitments that govern the company's activities.
Novartis welcomes interest from investors and other stakeholders concerned ESG topics and we aim to report comprehensively and transparently on our objectives and progress. Our ESG index shows where disclosures on key topics can be found across our publications and website.
Our commitment to being open and clearly disclosing what we do extends to our relationships with external stakeholders such as patients and patient organizations, healthcare professionals, policymakers and others. We also disclose our approach to animal research, to maintaining a safe workplace and to paying employees a living wage.
Animal research is governed by our animal welfare policy.
Clinical trials transparency
Providing information on clinical trials and their results serves everyone including study participants, patients and healthcare providers.
ESG rating performance
Ratings by Access to Medicine Index, CDP, MSCI, Sustainalytics and ISS ESG.
We aim to improve equity in healthcare and to create sustainable social and environmental impact.
We are committed to paying employees wages that cover basic living needs.
Patient organization funding
We work with groups that advocate for patients and disclose these relationships.
Payments to healthcare professionals
We publish payments to healthcare professionals and organizations in line with local laws or regulations.
We are transparent about our approach to engaging in public policy debates affecting our business.
Employee safety is an integral part of an employer’s responsibility.